Investigation of the Impact of Tryptophan‐Metabolizing Enzymes and Kynurenic Acid on Antibody‐Mediated Glomerulonephritis
The FASEB Journal · 30.09.2025 · 39 (18)
DOI: 10.1096/fj.202501800r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 23.09.2025. Verfasst von Ryosuke Umeda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Fujita Health University School of Medicine, Toyoake City, Aichi, Japan. Hauptthemen laut MEDLINE: Kynurenic Acid, Glomerulonephritis, Indoleamine-Pyrrole 2,3,-Dioxygenase, Tryptophan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science London (JSPS), Aichi Kidney Foundation, GlaxoSmithKline Japan (GSK).
Abstract (Originalsprache)
Tryptophan (TRP) metabolism through the kynurenine pathway generates multiple biologically active metabolites with diverse immunomodulatory effects, but their roles in glomerulonephritis (GN), particularly in innate immunity, remain poorly understood. Using a nephrotoxic serum‐induced GN (NTS‐GN) model, we first analyzed mice deficient in key TRP‐metabolizing enzymes of the kynurenine pathway: Indoleamine 2,3‐dioxygenase 1 and 2 (IDO1 and IDO2), and kynurenine 3‐monooxygenase (KMO), and found that Ido1 ‐deficient mice exhibited exacerbated kidney injury and glomerular neutrophil infiltration, whereas Ido2 deficiency had no significant impact. In contrast, Kmo ‐deficient mice showed reduced crescent formation. Unexpectedly, the concentration of kynurenic acid (KYNA), a downstream metabolite of IDO1, was elevated in the kidney cortex of Ido1 ‐deficient mice. Exogenous KYNA administration improved survival, ameliorated renal injury, and reduced neutrophil infiltration in Ido1 ‐deficient mice, indicating its protective effect against antibody‐mediated injury. Moreover, KYNA suppressed immune complex‐mediated neutrophil spreading, attenuated FcγR–dependent Syk phosphorylation, and reduced VEGF secretion in vitro. Our results position KYNA as a key modulator of neutrophil‐driven inflammation in antibody‐mediated GN. This study uncovers distinct roles for kynurenine pathway enzymes and highlights the TRP–KYNA pathway as a promising immunometabolic target for controlling innate immune responses in GN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Fujita Health University School of Medicine, Toyoake City, Aichi, Japan.
- Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake City, Aichi, Japan.
- Department of Advanced Diagnostic System Development, Fujita Health University School of Health Sciences, Toyoake City, Aichi, Japan.
ORCID-Profile: Ryosuke Umeda, Naotake Tsuboi
Förderung
- Japan Society for the Promotion of Science London (JSPS)
- Aichi Kidney Foundation
- GlaxoSmithKline Japan (GSK)
- Fujita Health University
Zitieren
APA
Umeda, R., Ito, Y., Minatoguchi, S., Koide, S., Takahashi, K., Hayashi, H., Hasegawa, M., Yuzawa, Y., Yamamoto, Y., Saito, K., & Tsuboi, N. (2025). Investigation of the Impact of Tryptophan‐Metabolizing Enzymes and Kynurenic Acid on Antibody‐Mediated Glomerulonephritis. The FASEB Journal, 39(18). https://doi.org/10.1096/fj.202501800r
Vancouver
Umeda R, Ito Y, Minatoguchi S, Koide S, Takahashi K, Hayashi H, et al. Investigation of the Impact of Tryptophan‐Metabolizing Enzymes and Kynurenic Acid on Antibody‐Mediated Glomerulonephritis. The FASEB Journal. 2025;39(18). doi:10.1096/fj.202501800r
BibTeX
@article{Umeda2025,
author = {Umeda, Ryosuke and Ito, Yoshimasa and Minatoguchi, Shun and Koide, Shigehisa and Takahashi, Kazuo and Hayashi, Hiroki and Hasegawa, Midori and Yuzawa, Yukio and Yamamoto, Yasuko and Saito, Kuniaki and Tsuboi, Naotake},
title = {Investigation of the Impact of Tryptophan‐Metabolizing Enzymes and Kynurenic Acid on Antibody‐Mediated Glomerulonephritis},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {18},
doi = {10.1096/fj.202501800r}
}
EUVIMED